110 related articles for article (PubMed ID: 28464952)
21. Preliminary evaluation of a small interfering RNA molecular probe targeting murine double minute 2 in breast cancer.
Wang X; Xu P; Jiao Y; Luan S; Gao Y; Zhao C; Fu P
Nucl Med Commun; 2022 Aug; 43(8):869-876. PubMed ID: 35582848
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Analysis of
Paiva I; Mattingly S; Wuest M; Leier S; Vakili MR; Weinfeld M; Lavasanifar A; Wuest F
Mol Pharm; 2020 May; 17(5):1470-1481. PubMed ID: 32233491
[TBL] [Abstract][Full Text] [Related]
23. In vitro/in vivo assessment of the targeting ability of [
Ranjbar L; Maleki F; Sadeghzadeh N; Abediankenari S; Mardanshahi A; Masteri Farahani A
Ann Nucl Med; 2020 Jul; 34(7):460-466. PubMed ID: 32390105
[TBL] [Abstract][Full Text] [Related]
24.
Molavipordanjani S; Khodashenas S; Abedi SM; Moghadam MF; Mardanshahi A; Hosseinimehr SJ
Eur J Pharm Sci; 2020 May; 148():105312. PubMed ID: 32198014
[TBL] [Abstract][Full Text] [Related]
25. GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma.
Zhou C; Xia Y; Wei Y; Cheng L; Wei J; Guo B; Meng F; Cao S; van Hest JCM; Zhong Z
Acta Biomater; 2020 Sep; 113():512-521. PubMed ID: 32562803
[TBL] [Abstract][Full Text] [Related]
26. Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11.
Judmann B; Wängler B; Schirrmacher R; Fricker G; Wängler C
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259420
[TBL] [Abstract][Full Text] [Related]
27. The Influence of Kidneys Ion Transport Inhibitors on the Pharmacokinetic and Tumor Uptake Behaviors of a HER2-targeted Small Size Radiolabeled Peptide.
Gharibkandi NA; Molavipordanjani S; Mardanshahi A; Hosseinimehr SJ
Curr Drug Metab; 2022; 23(1):82-87. PubMed ID: 35049428
[TBL] [Abstract][Full Text] [Related]
28. Investigation for anticancer activity of the newly synthesized
Farrag NS; Khater SI; Hassan FSM; Amin AM
Int J Radiat Biol; 2022; 98(8):1344-1357. PubMed ID: 35254964
[TBL] [Abstract][Full Text] [Related]
29. Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor.
Tang H; Rui M; Mai J; Guo W; Xu Y
Acta Pharm Sin B; 2020 Mar; 10(3):546-556. PubMed ID: 32140398
[TBL] [Abstract][Full Text] [Related]
30. Ligand-free
Cruz A; Pires RF; Raposinho P; Fernandes C; Paulo A; Bonifácio VDB
Chem Commun (Camb); 2024 May; ():. PubMed ID: 38819786
[TBL] [Abstract][Full Text] [Related]
31. GE11 positive exosomes as a potential RNAi delivery system in clear cell Renal Cell Carcinoma:
Adem B; Teixeira AL; Dias F; Ruivo C; Medeiros R; Melo SA
Porto Biomed J; 2017; 2(5):181. PubMed ID: 32258629
[No Abstract] [Full Text] [Related]
32. Synthesis, Radiolabeling, and
Braun D; Judmann B; Cheng X; Wängler B; Schirrmacher R; Fricker G; Wängler C
ACS Omega; 2023 Jan; 8(2):2793-2807. PubMed ID: 36687076
[TBL] [Abstract][Full Text] [Related]
33. Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors.
Judmann B; Braun D; Schirrmacher R; Wängler B; Fricker G; Wängler C
ACS Omega; 2022 Aug; 7(31):27690-27702. PubMed ID: 35967067
[TBL] [Abstract][Full Text] [Related]
34. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.
Holik HA; Ibrahim FM; Elaine AA; Putra BD; Achmad A; Kartamihardja AHS
Molecules; 2022 May; 27(10):. PubMed ID: 35630536
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of
Mohtavinejad N; Hajiramezanali M; Akhlaghi M; Bitarafan-Rajabi A; Gholipour N
Iran J Basic Med Sci; 2021 Nov; 24(11):1488-1499. PubMed ID: 35317117
[TBL] [Abstract][Full Text] [Related]
36. Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer.
Gaurav I; Wang X; Thakur A; Iyaswamy A; Thakur S; Chen X; Kumar G; Li M; Yang Z
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575511
[TBL] [Abstract][Full Text] [Related]
37. Peptide-Based Strategies for Targeted Tumor Treatment and Imaging.
Ayo A; Laakkonen P
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918106
[TBL] [Abstract][Full Text] [Related]
38. PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology.
Rinne SS; Orlova A; Tolmachev V
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915894
[TBL] [Abstract][Full Text] [Related]
39. Peptide Based Imaging Agents for HER2 Imaging in Oncology.
Ducharme M; Lapi SE
Mol Imaging; 2020; 19():1536012120960258. PubMed ID: 32957830
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
